We receive a lot of queries about hormone therapy from GPs and other healthcare professionals. To assist GPs and other healthcare professionals with such queries, we have put together this page, with links to the most current versions of our clinical information and guidance including:
- Shared care protocols
- Ongoing hormone monitoring & management leaflets
- Post discharge hormone management leaflets
- Hormone information booklets (our patient information leaflets)
Please note, this information is provided as reference material. The documents do not apply to individual patients/people.
We are happy to provide ongoing advice on monitoring and managing hormone therapy for patients currently under our care or who were previously under our care.
We cannot endorse hormone therapy, nor take responsibility for monitoring or managing hormone therapy, nor give individualised advice for patients/people we have not seen or assessed ourselves as this can be unsafe. When we receive queries such as these, we may direct GPs/healthcare professionals to the information here in the first instance. Where needed, we may be able to provide further general advice in the interest of safety and harm reduction.
Shared care prescribing guidance for treatment of gender dysphoria in people assigned male at birth transitioning to a feminine gender identity
The information contained in this document has been compiled in order to support GPs and other medical practitioners in safe prescribing and monitoring arrangements.
The document outlines the roles and responsibilities of the Gender Specialists, General Practitioners and Clients and contains both a shared care agreement and a client letter of consent for the initiation of hormones. It is imperative that clients who take the preparations, as listed, do so under medical supervision, and are monitored as recommended.
Please ensure that the latest updates on the medications and interactions, as listed, are obtained from the BNF.
Read or download ‘Shared Care Protocol Trans Feminine (PDF)
Shared care prescribing guidance for treatment of gender dysphoria in people assigned female at birth transitioning to a masculine gender identity
The information contained in this document has been compiled in order to support GPs and other medical practitioners in safe prescribing and monitoring arrangements.
The document outlines the roles and responsibilities of the Gender Specialists, General Practitioners and Clients and contains both a shared care agreement and a client letter of consent for the initiation of hormones. It is imperative that clients who take the preparations, as listed, do so under medical supervision, and are monitored as recommended.
Please ensure that the latest updates on the medications and interactions, as listed, are obtained from the BNF.
Read or download ‘Shared Care Protocol Trans Masculine (PDF)
Further information
Ongoing hormone monitoring and management leaflets
These documents provide ongoing hormone monitoring and management guidance. They are meant to be used as supplementary documents to our shared care protocols, serving as a quick glance dose titration and monitoring guide.
- Ongoing hormone monitoring and management information – Trans masculine
- Ongoing hormone monitoring and management information – Trans feminine
Post discharge hormone management leaflets
On discharge from our service, this is the information we send to GPs to guide immediate and longer-term monitoring and management of hormone therapy in primary care. The guidance is consistent with the ongoing hormone monitoring & management leaflet (above).
- Post discharge hormone management leaflet – Trans masculine
- Post discharge hormone management leaflet – Trans feminine
Hormone information booklets
These information booklets are typically given to patients at their initial appointment with our service, outlining what to expect from hormonal treatment and the risks (i.e., the benefits and risks), and also explains the monitoring requirements. These are currently being reviewed/updated.